Safety of aerosolized amphotericin B lipid complex in lung transplant recipients

Transplantation

Volumn 72, Issue 3, 2001, Pages 545-548

  Palmer, Scott M ^a   Drew, Richard H ^a,b   Whitehouse, James D ^a   Tapson, Victor F ^a   Duane Davis, R ^a   McConnell, Robert R ^a   Kanj, Souha S ^c   Perfect, John R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Campbell University   (United States)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIINFECTIVE AGENT; CYTOMEGALOVIRUS ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG TOLERABILITY; HEART LUNG TRANSPLANTATION; HUMAN; HUMAN TISSUE; LUNG MECHANICS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MYCOSIS; NAUSEA AND VOMITING; PRIORITY JOURNAL; SPIROMETRY; SURVIVAL; TASTE DISORDER;

EID: 0035881350     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200108150-00036     Document Type: Article

References (12)

1. Clinical aspects of fungal infection in organ transplant recipients
2. Fungal infections in lung and heart-lung transplant recipients
3. Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients
4. Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia
5. The physiologic effects of inhaled amphotericin B
6. Prophylactic efficacy of aerosolized liposomal (ambisome) and non-liposomal (furgizone) amphotericin B in murine pulmonary aspergillosis
7. Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis
8. The toxicity of daily inhaled amphotericin B
9. Lipoid pneumonia combined with pulmonary nocardiosis caused by inhalation of amphotericin-B after renal transplantation
10. Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: Results of a randomized prospective study
11. Antifungal prophylaxis during the early postoperative period of lung transplantation
12. Delivery and distribution of aerosolized cyclosporine in lung allograft recipients